The zebrafish has emerged as a robust vertebrate model for studying cardiac electrophysiology and pharmacology, owing to its genetic tractability, optical transparency during early stages, and ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...
Please provide your email address to receive an email when new articles are posted on . Advanced electrophysiology fellowship training is essential for operators conducting AF ablations. Complete ...
The use of the antipsychotic drugs quetiapine and haloperidol is associated with an increased risk of ventricular arrhythmias and sudden cardiac death (SCD) caused by drug-induced QT prolongation, ...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...
With heart disease as the leading cause of death worldwide, there is growing recognition that recovery is not only physical ...
First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...